Company

LIB Therapeutics

Biotechnology Research Cincinnati, Oh, United States 11 employees

Employees: 11
Contacts: 2
Emails: 2
Phones: 2

www.libtherapeutics.com LinkedIn

LIB Therapeutics Overview

Headquarters: Cincinnati, Oh, United States
Website: www.libtherapeutics.com
Industry: Biotechnology Research
Employees: 11
Founded: 2015
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

cardiovascular LDL-C lerodalcibep

About LIB Therapeutics

LIB Therapeutics is a privately held, late-stage biopharmaceutical company dedicated to bringing novel, safe and convenient subcutaneous and oral PCSK9 inhibitors to the millions of patients at very high and high-risk of cardiovascular disease (CVD), and the 30 million with familial hypercholesterolemia (FH), who require additional large reductions in low density lipoprotein-cholesterol (LDL-C) despite maximally tolerated statins and other lipid lowering agents.

LIB Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 2; 50.0% coverage

LIB Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Kate Caldwell, Mt(ascp)	Senior Director, Clinical Development at Lib Therapeutics, Llc		View
Michael Adelman	Sr. Life Science Executive	Greater Philadelphia, United States	Email Phone
Jason Grossman	VP of Commercial Operations, Board Advisor, Startup Expert. Delivering Scalable, Innovative Healthcare Solutions.	New York City Metropolitan Area, United States	Email Phone
Evan Stein	COO and Cso Lib Therapeutics Cincinnati. Ohio. Usa	Hollywood, Florida, United States	View